peyron's blog

ISU-Meridian pharmacy professor receives NIH grant to improve antibiotic use in hospitals

For Immediate Release / May 7, 2012 / Contact: Madaras-Kelly;kmk@pharmacy.isu.edu

STUDY FIRST TO SHOW INFLUENZA A VIRUS IN PARKINSON’S BRAIN CELLS

By Sherry Squires

Boise State Focus Magazine

Could a flu vaccine help prevent Parkinson’s or Alzheimer’s disease?

Research by Dr . Troy Rohn in the Department of Biological Sciences at Boise State University is the first to show the presence of the influenza A virus in brains of individuals who died of Parkinson’s, offering new scientific data to support theories that a virus might trigger the disease .

“If I told you catching a common illness may increase your risk for Parkinson’s disease, you probably would say I am crazy,” Rohn said . “But it’s definitely a possibility .”

While the cause of Parkinson’s is unknown, scientists long have suspected that infection may play a role and there has been a good deal of anecdotal data to support the theory . But no previous scientific study has shown actual evidence of the influenza A virus in post- mortem brain tissue .

Rohn, whose primary research interest is Alzheimer’s disease, discovered the Parkinson’s disease connection earlier this year while studying proteins in the brains of Alzheimer’s patients . He became curious if the same proteins existed in the brains of those who died from Parkinson’s disease .

“We were looking for something totally different when we came across immune cells that you don’t usually find in the brain,” said Rohn . “The cells are only present when there is an infec- tion to fight off . We began to look more closely and found influenza A virus .”

The virus was found in the area of the brain where Parkinson’s disease originates . The study will have to be replicated with larger sample sizes, but it is an important first link to studies that have correlated a possible viral infection with contracting Parkinson’s disease later in life .

Rohn’s work at Boise State also has led to the development of an antibody that will help other researchers who are trying to determine triggers for a number of degenerative diseases . The university signed a licensing agreement this summer to make the antibody — the first developed at Boise State to be licensed — to biomedical researchers around the globe .

Rohn came to Boise State in 2000 . His research focuses on neurodegenerative diseases such as Alzheimer’s and the process by which apoptosis, or programmed cell death, occurs.

 

Idaho Falls: Health Care Reform – Implications and Implementation in Idaho

Friday, April 20, 2012

7:30 AM to 12:00 PM (MT)
Idaho Falls, ID
 
This is one of a four Forums the Idaho Business Review will present statewide to educate employees and employers about this time sensitive topic of Health Care Reform.

Please register for Idaho Falls Forum by April 18th, if you have not already.

New, Loosened Restrictions on Securities Offerings by Small Idaho Businesses

March 29, 2012

By: Richard Riley, partner of Hawley Troxell Ennis & Hawley LLP, member of The CORE

The Idaho Department of Finance (DOF) recently approved a new exemption from securities registration requirements to make it easier for small businesses to access capital without running afoul of securities laws. The new exemption allows small businesses to offer securities using general advertising and public solicitation, while maintaining appropriate investor protections.

Syndicate content